(1-(P-tolyl)cyclopropyl)methanamine, 98%, 100mg

N-methyl-2-(tetrahydro-2H-pyran-2-yl)ethanamine hydrochloride, 95.0%, 1g

2-Amino-5-bromo-4-chlorophenol, 95+%, 1g

3-(Bromomethyl)-5-chlorobenzo[b]thiophene, 97.0%, 100g

6-Fluoro-2-(piperidin-4-yl)-2,3-dihydro-1H-isoindol-1-one, 1g

5-amino-N,1-dimethyl-1H-pyrazole-4-carboxamide, 95.0%, 1g

4-[2-(Dimethylamino)ethoxy]benzylamine, 97.0%, 5g

1-((2'-Cyano-[1,1'-biphenyl]-4-yl)methyl)-2-ethoxy-1h-benzo[d]imidazole-7-carboxylic acid, 97%, 1g

1-Benzyl-4-phenylamino-4-cyano-piperidine, 95.0%, 25g

5-METHOXYQUINOLIN-3-AMINE, 95.0%, 250mg

4-(2-Trifluoromethyl-phenyl)-pyridine-2-carbonitrile, 95.0%, 1g

Tube à essai ROTILABO® à bord perlé, à paroi mince, 9 ml, 100 unité(s), 100 Pièce(s)

2,2-Dimethyl-2,3-dihydropyrazolo[5,1-b]oxazole, 97%, 100mg